Drawing for SMARTSEDLINE

USPTO serial 99423309

SMARTSEDLINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARTIN, EUGENIA K
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with SMARTSEDLINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Deborah S. Shepherd

Deborah S. Shepherd Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorKnobbe, Martens, Olson & Bear, LLPIrvine, CA 92614

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software using machine learning for applying computational methods in the fields of medical technology and monitoring a person's health and wellness; Downloadable computer programs using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and wellness; Recorded computer programs using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and wellness; Software as a Medical Device (SaMD), recorded, for use as a medical instrument for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties; Downloadable software for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties; Recorded software for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties; Circuit boards; Computer hardware; Downloadable computer firmware for operating system programs in the fields of medical technology and monitoring a person's health and wellness; Recorded computer firmware for operating system programs in the fields of medical technology and monitoring a person's health and wellness; Software as a Medical Device (SaMD), downloadable, for use as a medical instrument for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood propertiesACTIVE—
010Medical apparatus and instruments for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties; Medical apparatus and instruments for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties, and recorded software for recording, analyzing, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties, and recorded software using machine learning for applying computational methods, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties, and recorded software using artificial intelligence (AI) for recording, analyzing, processing and transmitting medical data, for use therewith, sold as a unit; Wearable monitors used to measure biometric data for medical use; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Sensors for medical use to be worn by a human to gather human biometric data and also including recorded software for recording, analyzing, processing and transmitting medical data, for use therewith, sold as a unit​​​​​ACTIVE—
042Providing online non-downloadable software using artificial intelligence (AI) for machine learning; Software as a service (SAAS) services featuring machine learning software for enabling computers to learn to perform tasks autonomously; Providing online non-downloadable software using machine learning for applying computational methods in the fields of medical technology and monitoring a person's health and wellness; Software as a service (SAAS) services featuring software using machine learning for applying computational methods in the fields of medical technology and monitoring a person's health and wellness; Providing on-line non-downloadable software using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and wellness; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and wellness; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for use in software development and machine learning in the fields of medical technology and monitoring a person's health and wellness; Providing temporary use of on-line non-downloadable software for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood properties; Software as a service (SAAS) services featuring software for monitoring blood oxygen levels, brain function, vital signs, heart rate, blood pressure, breathing, physical motion of humans, and blood propertiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 1, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 1, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 1, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 1, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 1, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 3, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 30, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 9, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 9, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jun 9, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 9, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 9, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 26, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 4, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 17, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 1, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance